Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2012
10/04/2012US20120251579 Compositions for generating an antigen specific immune response
10/04/2012US20120251570 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
10/04/2012US20120251569 Composition for treating hbv infection
10/04/2012US20120251568 Recombinant influenza viruses and uses thereof
10/04/2012US20120251563 Modulation of immune response by non-peptide binding stress response polypeptides
10/04/2012US20120251554 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
10/04/2012US20120251540 Stabilized single domain antibodies
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251529 Anti-cea antibodies
10/04/2012US20120251527 Podocyte specific assays and uses thereof
10/04/2012US20120251520 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
10/04/2012US20120251514 Modulated programmed death ligand-1
10/04/2012US20120251513 Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and Systems
10/04/2012US20120251510 Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood
10/04/2012US20120251509 Cell-based anti-cancer compositions and methods of making and using the same
10/04/2012US20120251506 Methods and compositions relating to neuronal cell and tissue differentiation
10/04/2012US20120251498 Gene Delivery to Organs
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/04/2012US20120247150 Magnetic Glass Particles, Method for Their Preparation and Uses Thereof
10/04/2012DE112010004821T5 Prozessierung amplifizierter DNA-Fragmente zur Sequenzierung Processing of amplified DNA fragments for sequencing
10/04/2012DE102004038535B4 Zelluläre Einschleusung von Nukleinsäurewirkstoffen Cellular introduction of nucleic acid drugs
10/04/2012CA2832151A1 Methods and compositions for treating brain diseases
10/04/2012CA2831927A1 Mutant bacillus thuringiensis cry genes and methods of use
10/04/2012CA2831915A1 Modulation of signal transducer and activator of transcription 3 (stat3) expression
10/04/2012CA2831907A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
10/04/2012CA2831885A1 Microorganisms for producing methacrylic acid and methacrylate esters and methods related thereto
10/04/2012CA2831829A1 Genetic engineering methods and materials for enhancing plant yields
10/04/2012CA2831771A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012CA2831770A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012CA2831769A1 Membrane-separation-type culture device, membrane-separation-type culture kit, stem cell separation method using same, and separation membrane
10/04/2012CA2831481A1 Compositions and methods for treating, diagnosing and monitoring disease
10/04/2012CA2831284A1 Compositions and methods for inhibiting expression of tmprss6 gene
10/04/2012CA2831133A1 Plant regulatory elements and uses thereof
10/04/2012CA2830990A1 Novel immunoglobulin-binding polypeptide
10/04/2012CA2830338A1 Antibody-drug conjugates
10/04/2012CA2830305A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/04/2012CA2829105A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012CA2827774A1 Regulated gene expression systems and constructs thereof
10/03/2012EP2505666A1 Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides
10/03/2012EP2505662A1 Method and apparatus for prediction of pharmacological efficacy of humanized anti-tnf antibody drug on rheumatoid arthritis
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2505654A1 Common light chain mouse
10/03/2012EP2505653A2 Transgenic plants with increased stress tolerance and yield
10/03/2012EP2505652A1 Plants having enhanced yield-related traits and a method for making the same
10/03/2012EP2505651A2 Isolated fungus with reduced protease activity
10/03/2012EP2505650A1 Compounds and methods for modulating expression of PCSK9
10/03/2012EP2505649A1 Compounds and methods for modulating expression of GCGR
10/03/2012EP2505648A1 Compounds and methods for modulating expression of PTP1B
10/03/2012EP2505647A1 Compounds and methods for modulating expression of DGAT2
10/03/2012EP2505646A1 Compounds and methods for modulating expression of CRP
10/03/2012EP2505645A1 MicroRNA as a cancer progression predictor and its use for treating cancer
10/03/2012EP2505640A1 Vaccine compositions for birnavirus-borne diseases
10/03/2012EP2504457A2 Novel genomic biomarkers for irritable bowel syndrome diagnosis
10/03/2012EP2504453A2 Assay method for target nucleic acid by signal amplification using probe hybridization and restriction
10/03/2012EP2504444A1 Retroviral vector particles and methods for their generation and use
10/03/2012EP2504443A1 Conditional expression of transgenes in vivo
10/03/2012EP2504442A1 Banana promoters
10/03/2012EP2504441A1 Sucrose transporter genes for increasing plant seed lipids
10/03/2012EP2504440A1 Maternally induced sterility in animals
10/03/2012EP2504439A1 Optimized endonucleases and uses thereof
10/03/2012EP2504438A1 Novel fatty acid elongase and uses thereof
10/03/2012EP2504437A2 Assays for mutagenesis detection
10/03/2012EP2504436A1 Aptamers directed against the matrix protein-1 of type a influenza viruses and uses thereof
10/03/2012EP2504435A1 Sirna compounds comprising terminal substitutions
10/03/2012EP2504434A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation
10/03/2012EP2504433A2 Allelic ladder loci
10/03/2012EP2504430A1 Chimeric endonucleases and uses thereof
10/03/2012EP2504429A1 Chimeric endonucleases and uses thereof
10/03/2012EP2504427A1 Novel fatty acid desaturase and uses thereof
10/03/2012EP2504421A2 Methods and compositions for producing squalene using yeast
10/03/2012EP2504363A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
10/03/2012EP2504357A2 Recombinant filaggrin polypeptides for cell importation
10/03/2012EP2504355A1 Method for making polypeptides
10/03/2012EP2504029A1 Compositions, methods and uses for expression of enterobacterium-associated peptides
10/03/2012EP2504027A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
10/03/2012EP2503874A1 Control of aad dicot volunteers in monocot crops
10/03/2012EP2503872A1 Transgenic maize event mon 87427 and the relative development scale
10/03/2012EP2503871A1 Aad-12 event 416, related transgenic soybean lines, and event-specific identification thereof
10/03/2012EP1343874B1 Cells comprising lactyl-coa dehydratase, 3-hydroxypropionyl-coa dehydratase or a multienzyme complex isolated from megasphaera elsdenii and chloroflexus aurantiacus for the production of 3-hydroxypropionic acid
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN1890266B Antibodies
10/03/2012CN1759176B Diagnosis and treatment of multiple sulfatase deficiency andother sulfatase deficiencies using a formylglycine generating enzyme (FGE)
10/03/2012CN1695638B Probiotic therapy of neonatal meningitis and method of using e. coli virulence determinatns
10/03/2012CN1662662B Nucleic acid sequencing by signal stretching and data integration
10/03/2012CN1646561B Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
10/03/2012CN102712953A Recurrent gene fusions in prostate cancer
10/03/2012CN102712936A Method for producing chemicals by continuous fermentation
10/03/2012CN102712935A Nucleic acid-containing lipid particles and related methods
10/03/2012CN102712934A Recombinant adenovirus having anti-angiogenesis activity
10/03/2012CN102712933A Regulated expression systems
10/03/2012CN102712931A Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
10/03/2012CN102712930A Porcine torque teno virus vaccines and diagnosis
10/03/2012CN102712928A Antisense antiviral compound and method for treating influenza viral infection
10/03/2012CN102712927A Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
10/03/2012CN102712926A Composition for inhibiting gene expression and uses thereof
10/03/2012CN102712925A Treatment of SIRTUIN (SIRT) related diseases by inhibition of natural antisense transcript to a SIRTUIN (SIRT)
10/03/2012CN102712924A Combination of a chemotherapeutic agent and an inhibitor of the TGF-[beta] system
10/03/2012CN102712923A Anti-iga1 antibody
1 ... 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 ... 4023